AU6266896A - Transvacular and intracellular delivery of lipidized protein s - Google Patents
Transvacular and intracellular delivery of lipidized protein sInfo
- Publication number
- AU6266896A AU6266896A AU62668/96A AU6266896A AU6266896A AU 6266896 A AU6266896 A AU 6266896A AU 62668/96 A AU62668/96 A AU 62668/96A AU 6266896 A AU6266896 A AU 6266896A AU 6266896 A AU6266896 A AU 6266896A
- Authority
- AU
- Australia
- Prior art keywords
- transvacular
- intracellular delivery
- lipidized protein
- lipidized
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940096437 Protein S Drugs 0.000 title 1
- 230000003834 intracellular effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48211695A | 1995-06-07 | 1995-06-07 | |
US482116 | 1995-06-07 | ||
PCT/US1996/009788 WO1996040248A1 (en) | 1995-06-07 | 1996-06-06 | Transvacular and intracellular delivery of lipidized proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6266896A true AU6266896A (en) | 1996-12-30 |
Family
ID=23914739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62668/96A Abandoned AU6266896A (en) | 1995-06-07 | 1996-06-06 | Transvacular and intracellular delivery of lipidized protein s |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6266896A (en) |
WO (1) | WO1996040248A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2344886B (en) | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
US20030082191A1 (en) | 2001-08-29 | 2003-05-01 | Poduslo Joseph F. | Treatment for central nervous system disorders |
CN1867581B (en) * | 2003-10-10 | 2012-02-01 | 诺沃挪第克公司 | IL-21 derivatives |
US20060228331A1 (en) | 2003-10-10 | 2006-10-12 | Novo Nordisk A/S | IL-21 Derivatives and variants |
AU2007310777A1 (en) | 2006-10-26 | 2008-05-02 | Novo Nordisk A/S | IL-21 variants |
EP2756005B1 (en) | 2011-09-14 | 2016-03-02 | Abeterno Technologies Limited | Intracellular cell selection |
GB201306589D0 (en) | 2013-04-11 | 2013-05-29 | Abeterno Ltd | Live cell imaging |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0462145T3 (en) * | 1989-03-07 | 1994-08-08 | Genentech Inc | Covalent conjugates between lipid and oligonucleotide |
-
1996
- 1996-06-06 AU AU62668/96A patent/AU6266896A/en not_active Abandoned
- 1996-06-06 WO PCT/US1996/009788 patent/WO1996040248A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO1996040248A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5424196A (en) | Intracellular signaling proteins and methods of use | |
AU5928696A (en) | Intracellular delivery of macromolecules | |
AU1682699A (en) | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof | |
ZA962116B (en) | Protein production and delivery | |
AU6307698A (en) | Useful properties of human lactoferrin and variants thereof | |
AU6030398A (en) | Human proteins | |
AU1088399A (en) | F-box proteins and genes | |
AU1021997A (en) | Cd100 antigen and uses therefor | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
OA09893A (en) | Transvascular and intracellular delivery of lipidized proteins. | |
AU7721796A (en) | Skin care preparation and method | |
AU7621496A (en) | Microsensor and use of such microsensor | |
AU7290898A (en) | Preparation of fagopyritols and uses therefor | |
AU3092995A (en) | Breast specific genes and proteins | |
AUPN631495A0 (en) | Vaccine and biological vector(I) | |
AU6266896A (en) | Transvacular and intracellular delivery of lipidized protein s | |
AUPN631395A0 (en) | Vaccine and biological vector(II) | |
AU7015396A (en) | Cyclin e variants and use thereof | |
ZA96240B (en) | Novel peptides their preparation and use | |
AU9017598A (en) | Human frezzled-like protein | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU5369396A (en) | Rest protein and dna | |
AU8168898A (en) | Interferon stimulating protein and uses thereof | |
AU4459196A (en) | Sustained-release preparation and use | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof |